sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Asia Pacific Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Country: Trend Forecast and Growth Opportunity

Asia Pacific Oncology Informatics Market 2020-2030 by Product Type (EHR,...

Home / Categories / Healthcare
Asia Pacific Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Country: Trend Forecast and Growth Opportunity
Asia Pacific Oncology Informatics Market...
Report Code
RO1/105/1045

Publish Date
26/Aug/2020

Pages
113
PRICE
$ 2900/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 3900/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 5000/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Asia Pacific oncology informatics market will grow by 7.8% annually with a total addressable market cap of $16.75 billion over 2020-2030 owing to the surge of cancer incidence, increasing cost of cancer treatment, and growing trend of reducing medical errors and readmission rates.
Highlighted with 34 tables and 46 figures, this 113-page report "Asia Pacific Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Asia Pacific oncology informatics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porters Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific oncology informatics market in every aspect of the classification from perspectives of Product Type, Cancer Type, Application, End User, and Country.

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Electronic Health Records (EHRs)
- Population Health Management (PHM)
- Clinical Decision Support System (CDSS)
- Drug Discovery and Development Informatics (DDDI)
- Data Analytics
- Image Analytics
- Other Product Types

Based on Cancer Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Cervical Cancer
- Other Cancers

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Medical Application
- Surgical Application
- Radiation Application

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- Pharmaceutical Companies
- Life Science Companies
- Contract Research Organizations (CROs)
- Academic Institutes and Research Centers
- Other End Users

Geographically, the following national/local markets are fully investigated:
- Japan
- China
- South Korea
- Australia
- India
- Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Cancer Type, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific oncology informatics market are assayed quantitatively and qualitatively through GMDs Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Cerner Corporation
Change Healthcare
Elekta AB
F.Hoffmann-La Roche Ltd.
Hologic Inc.
IBM Corporation
Inspirata Inc.
Koninklijke Philips N.V.
Laboratory Corporation of America Holdings
McKesson Corporation
MIM Software, Inc.
Oncology Analytics, Inc
PerkinElmer, Inc.
RELX Group
Sirenas, LLC
UnitedHealth Group, Inc
Varian Medical Systems, Inc
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com